LRG1 and cancer: In this rare cancer (Shaib and El-Serag, 2004), our discovery analysis of pooled serum samples using immunoaffinity depletion, 2D-DIGE and LC-MS/MS was able to detect differential protein expression between the BTC, benign and healthy groups, including upregulation of the putative marker LRG1.